Rasib M. Raja , Mark S. Kramer , Jerry L. Rosenbaum
28 November 2008
The present study compared clearance (K) for urea (U), uric acid (Ua), and BSP in relatively equal surface area dialyzers, EX-29 to dual EX-21 in parallel (DEX-21) at Q<sub>B</sub> and Q<sub>D</sub> 300 ml/min, and hollow fiber kidney model 5 (HFK-5) to dual HFK model 4 in series (DHFK-4) at Q<sub>B</sub> 200, Q<sub>D</sub> 500 ml/min. K<sub>U</sub> was 158 ± 20 ml/min, 129 ± 22; K<sub>Ua</sub> was 106 ± 10,96 ± 5, and K<sub>BSP</sub> was 80 ± 11 and 67 ± 12 (p < 0.01) for EX-29 and DEX-21, respectively. K<sub>U</sub> was 173 ± 8 ml/min, 159 ± 6; K<sub>Ua</sub> was 131 ± 6, 117 ± 8, and K<sub>BSP</sub> was 65 ± 9 and 56 ± 7 (p < 0.01) for HFK-5 and DHFK-4, respectively. Comparable changes in outlet pressure had a varied effect on ultrafiltration and solute transport. 3-hour hemodialysis in the same patients showed that EX-29 was better tolerated than DEX-21. The data suggest that dialyzer designs with the same membrane of equal surface area may significantly affect K for both small and middle molecular weight solutes. Comparable changes in outlet pressure may have a varied effect on K in different designs. Due to these variations, comparison of dialysis schedules with different dialyzers on the basis of the square meter hour dialysis to prove validity of middle molecule hypothesis should be interpreted cautiously.
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.